DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

SBI Cards and Payment Services Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 43 min ago·7 Oct 2026, 10:57 am

SBI Cards & PAY SER

SBI Cards and Payment Services Limited has filed a regulatory certificate with stock exchanges, confirming compliance with SEBI's Depositories and Participants Regulations, 2018. This filing is a standard procedural requirement that the company must complete to maintain its listing status and adhere to market regulations.

For investors, this update is largely procedural and does not signal any operational changes or financial distress. It serves as a confirmation that the company is in good standing with market watchdogs, ensuring its shares continue to trade smoothly on the exchange.

Investors should continue to monitor the company's regular financial disclosures and business performance updates. While this specific filing is routine, staying informed about broader regulatory compliance and quarterly results remains key to assessing the stock's future trajectory.